Edgewise Therapeutics (EWTX) Stock Chart & Stock Price History $18.83 +1.26 (+7.17%) (As of 09/13/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Edgewise Therapeutics Stock Price Performance5 Day Performance+7.48%1 Month Performance+10.18%3 Month Performance+5.14%6 Month Performance+8.16%Year-To-Date Performance+72.12%1 Year Performance+195.60% Receive EWTX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Edgewise Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Porter & CompanyWar on Elon Escalates… Elon Musk, the guy slated to become the world’s first trillionaire by 2027, has publicly called for the adoption of this technology for decades. By doing so he has put himself in the crosshairs of an ideological war with the global elites. And yet, while this new technology threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.Click here to learn how you can benefit from its widespread distribution. EWTX Stock Chart for Friday, September, 13, 2024 EWTX Chart by TradingView Edgewise Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization09/13/2024$17.57$18.83+7.17%$18.93$17.55739,549 shs$1.77 billion09/12/2024$16.85$17.57+4.27%$18.26$16.871.16 million shs$1.64 billion09/11/2024$17.27$16.85-2.43%$17.32$16.72447,256 shs$1.57 billion09/10/2024$17.60$17.27-1.88%$17.83$16.98356,578 shs$1.62 billion09/09/2024$17.52$17.60+0.46%$17.98$17.27486,963 shs$1.65 billion09/06/2024$17.47$17.52+0.29%$17.59$17.02733,582 shs$1.64 billion Get the Latest News and Ratings for EWTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Edgewise Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 09/05/2024$17.93$17.47-2.57%$18.16$17.38527,773 shs$1.63 billion09/04/2024$17.88$17.93+0.28%$18.28$17.61507,124 shs$1.67 billion09/03/2024$18.75$17.88-4.64%$19.42$17.681.08 million shs$1.67 billion09/02/2024$18.75$18.75$18.94$18.261.13 million shs$1.75 billion08/30/2024$18.42$18.75+1.79%$18.94$18.261.13 million shs$1.75 billion08/29/2024$18.85$18.42-2.28%$19.22$18.22913,624 shs$1.72 billion08/28/2024$19.78$18.85-4.70%$19.77$18.84515,010 shs$1.76 billion08/27/2024$20.19$19.78-2.03%$20.34$19.54508,647 shs$1.85 billion08/26/2024$19.33$20.19+4.45%$20.31$19.22719,662 shs$1.89 billion08/23/2024$19.59$19.33-1.33%$20.42$19.23866,779 shs$1.81 billion08/22/2024$20.94$19.59-6.45%$21.04$19.49684,880 shs$1.83 billion08/21/2024$19.72$20.94+6.19%$21.00$19.461.13 million shs$1.96 billion08/20/2024$18.82$19.72+4.78%$20.30$18.80692,838 shs$1.84 billion08/19/2024$18.45$18.82+2.01%$19.18$18.22542,180 shs$1.76 billion08/16/2024$18.87$18.45-2.23%$19.20$18.05560,394 shs$1.72 billion08/15/2024$17.05$18.87+10.67%$18.97$17.531.22 million shs$1.76 billion08/14/2024$17.09$17.05-0.23%$17.37$16.781.63 million shs$1.59 billion08/13/2024$17.05$17.09+0.23%$17.36$16.62944,397 shs$1.60 billion08/12/2024$16.45$17.05+3.65%$17.50$16.25688,450 shs$1.59 billion08/09/2024$16.19$16.45+1.61%$16.70$15.94418,712 shs$1.54 billion08/08/2024$15.88$16.19+1.95%$16.54$15.51573,319 shs$1.51 billion08/07/2024$16.07$15.88-1.18%$16.56$15.47552,582 shs$1.48 billion08/06/2024$15.89$16.07+1.13%$16.50$15.55611,584 shs$1.50 billion08/05/2024$16.25$15.89-2.22%$16.06$15.02922,126 shs$1.48 billion08/02/2024$16.75$16.25-2.99%$16.53$15.68959,619 shs$1.52 billion08/01/2024$17.03$16.75-1.64%$17.54$16.652.16 million shs$1.56 billion07/31/2024$17.04$17.03-0.06%$17.55$16.89636,083 shs$1.59 billion07/30/2024$18.03$17.04-5.49%$18.39$16.731.05 million shs$1.59 billion07/29/2024$18.98$18.03-5.01%$19.39$17.90768,945 shs$1.68 billion07/26/2024$18.73$18.98+1.33%$20.24$18.73997,783 shs$1.75 billion07/25/2024$21.18$18.73-11.57%$21.52$18.412.13 million shs$1.75 billion07/24/2024$21.78$21.18-2.75%$22.07$20.84462,379 shs$1.98 billion07/23/2024$21.96$21.78-0.82%$22.23$21.73638,776 shs$2.03 billion07/22/2024$21.36$21.96+2.81%$22.06$21.23811,272 shs$2.05 billionWar on Elon Escalates… (Ad)Elon Musk, the guy slated to become the world’s first trillionaire by 2027, has publicly called for the adoption of this technology for decades. By doing so he has put himself in the crosshairs of an ideological war with the global elites. And yet, while this new technology threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.Click here to learn how you can benefit from its widespread distribution.07/19/2024$20.85$21.36+2.45%$21.77$20.60637,226 shs$2.00 billion07/18/2024$21.49$20.85-2.98%$21.65$20.50457,775 shs$1.95 billion07/17/2024$22.20$21.49-3.20%$22.00$20.94826,162 shs$2.01 billion07/16/2024$22.87$22.20-2.93%$23.42$22.15788,907 shs$2.07 billion07/15/2024$22.42$22.87+2.01%$23.50$22.42647,104 shs$2.14 billion07/12/2024$22.33$22.42+0.40%$23.23$21.71918,531 shs$2.09 billion07/11/2024$21.52$22.33+3.76%$23.00$21.91800,469 shs$2.09 billion07/10/2024$22.85$21.52-5.82%$23.19$21.45964,675 shs$2.01 billion07/09/2024$20.92$22.85+9.23%$23.10$20.801.48 million shs$2.13 billion07/08/2024$19.43$20.92+7.67%$20.99$19.35784,135 shs$1.95 billion07/05/2024$18.28$19.43+6.29%$19.47$18.24434,932 shs$1.81 billion07/04/2024$18.28$18.28$18.87$17.71505,702 shs$1.71 billion07/03/2024$18.38$18.28-0.54%$18.87$17.71505,672 shs$1.71 billion07/02/2024$19.38$18.38-5.16%$19.81$17.99626,918 shs$1.72 billion07/01/2024$18.01$19.38+7.61%$19.76$17.511.36 million shs$1.81 billion06/28/2024$17.50$18.01+2.91%$18.50$17.565.31 million shs$1.68 billion06/27/2024$17.48$17.50+0.11%$17.55$17.061.08 million shs$1.63 billion06/26/2024$17.39$17.48+0.52%$17.84$16.851.52 million shs$1.63 billion06/25/2024$16.71$17.39+4.07%$17.50$16.52659,014 shs$1.62 billion06/24/2024$17.05$16.71-1.99%$17.43$16.55344,155 shs$1.56 billion06/21/2024$16.81$17.05+1.43%$17.76$17.011.46 million shs$1.59 billion06/20/2024$16.18$16.81+3.89%$17.14$16.04844,084 shs$1.57 billion06/19/2024$16.18$16.18$17.27$15.87502,378 shs$1.51 billion06/18/2024$17.37$16.18-6.85%$17.27$15.87502,378 shs$1.51 billion06/17/2024$17.51$17.37-0.80%$17.72$17.13605,083 shs$1.62 billion06/14/2024$17.91$17.51-2.23%$18.00$17.20464,088 shs$1.64 billion06/13/2024$17.88$17.91+0.17%$18.13$17.55342,691 shs$1.67 billion06/12/2024$17.10$17.88+4.56%$18.17$17.20470,165 shs$1.67 billion Related Companies: Kura Oncology Stock Chart AnaptysBio Stock Chart Arcturus Therapeutics Stock Chart MaxCyte Stock Chart Solid Biosciences Stock Chart Heron Therapeutics Stock Chart Gossamer Bio Stock Chart Viking Therapeutics Stock Chart BridgeBio Pharma Stock Chart Cytokinetics Stock Chart Receive EWTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Edgewise Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:EWTX) was last updated on 9/13/2024 by MarketBeat.com Staff From Our Partners Turn Smartphones Into “Earnphones”?High-Growth Smartphone Startup 45 Million Users. $60M+ in Revenue. 32,481% Growth Rate. $1T+ market opportu...Mode Mobile | SponsoredChina Stockpiling Gold “Like No Tomorrow”For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a populat...True Gold Republic | SponsoredGold Set to EXPLODE!The perfect storm is brewing to drive gold's price through the roof! And our weakening dollars are causing ...Gold Safe Exchange | SponsoredWhy Institutions Are Bullish on BitcoinThe recent dip in the crypto market might be stressful… But it also presents a tremendous opportunity for s...Crypto 101 Media | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored625,000% GainThe recent pullback in the crypto markets has left many investors in full-on panic mode, convinced the bull ru...Crypto Swap Profits | SponsoredUnlock the Secret to Easy Wins with Iron CondorsDiscover the power of Iron Condor trades – a low-risk, high-reward strategy that allows you to profit consiste...Netpicks | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Edgewise Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Edgewise Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.